Clinical Conversations - Page 19 of 20 - Molecular testing content for clinical lab professionals and clinicians

Economic recovery can begin with corporations

Business continuity, testing, and the rising coronavirus-positive case count in the US

highly transmissible variant of SARS-CoV-2 discovered in the United Kingdom, B.1.1.7

The S Gene Advantage: TaqPath COVID-19 Tests May Help Early Identification of B.1.1.7

specificity and sensitivity of PCR tests

COVID-19 PCR Testing Assay Comparison by expert, Dr. Paul Granato

coronavirus with world map

New survey shows confusion on COVID-19 testing

workflow for sanger sequencing detection of s gene variants

Solutions for surveillance of the S gene mutation in the B.1.1.7 (501Y.V1) SARS-CoV-2 strain lineage

Mark Stevenson, Executive Vice President and Chief Operating Officer, Thermo Fisher Scientific

Thermo Fisher Scientific Joins Amazon and CVS Health in Coalition to Promote Expanded Workplace Testing

Coronavirus

Thermo Fisher’s COVID-19 tests: designed with virus mutations in mind

Clinical Laboratory Experience with TaqPath COVID-19 Testing

Thermo Fisher Scientific’s size, scale, and worldwide presence makes it uniquely suited to tackling global problems like SARS-CoV-2.

How Thermo Fisher Scientific Responded to SARS-CoV-2

1
…
17
18
19
20